Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001599298-20-000001
Filing Date
2020-01-02
Accepted
2020-01-02 16:39:14
Documents
1
Effectiveness Date
2020-01-02
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9740
  Complete submission text file 0001599298-20-000001.txt   10978
Mailing Address 136A EASTERN AVENUE MILTON PARK ABINGDON X0 OX14 4SB
Business Address 136A EASTERN AVENUE MILTON PARK ABINGDON X0 OX14 4SB 44-123-544-3939
Summit Therapeutics plc (Filer) CIK: 0001599298 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0131
Type: D | Act: 33 | File No.: 021-357007 | Film No.: 20501986
SIC: 2834 Pharmaceutical Preparations